Vertex Pharmaceuticals (VX1) Q1 2026 Earnings Report
DE:VX1 Q1 2026 EPS Results
- Actual EPS
- EUR 4.00
- Consensus EPS
- EUR 3.80
- Beat/Miss
- Beat by +EUR 0.20
- One Year Ago EPS
- EUR 3.64
DE:VX1 Q1 2026 Revenue Results
- Actual Revenue
- EUR 2.70B
- Expected Revenue
- EUR 2.68B
- Beat/Miss
- Beat by +EUR 16.30M
- YoY Revenue Growth
- +9.70%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/04/2026
- Time
- After Close
- Conference Call
- Monday, May 4, 2026
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:VX1 Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | ―- | 4.5 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.31- | 4.3 | ― | |
| Aug 03, 2026 | 2026 (Q2) | 4.254.24 | 4.05 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.804.00 | 3.64 | 10.10% (+0.37) | |
| Feb 12, 2026 | 2025 (Q4) | 4.584.50 | 3.56 | 26.38% (+0.94) | |
| Nov 03, 2025 | 2025 (Q3) | 4.094.30 | 3.92 | 9.59% (+0.38) | |
| Aug 06, 2025 | 2025 (Q2) | 3.844.05 | -11.49 | 135.23% (+15.54) | |
| May 05, 2025 | 2025 (Q1) | 3.873.64 | 4.26 | -14.71% (-0.63) | |
| Feb 10, 2025 | 2024 (Q4) | 3.603.56 | 3.76 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.653.92 | 3.65 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
